US20070073381A1 - Expandable stent having a dissolvable portion - Google Patents

Abstract

An expandable stent having a covering which exhibits the characteristic of upon being activated by applying an agent to the covering, dissolving to expose a portion of the underlying stent. The stent may be placed across the neck of an aneurysm to seal the aneurysm and thereafter a selected region of the covering may be dissolved by an activating agent to permit blood to flow to adjacent vessels.

Description

CROSS-REFERENCE TO RELATED APPLICATIONS(S)
• This patent application is a divisional patent application of U.S. patent application Ser. No. 10/976,412 (Attorney Docket No. CRD5045USNP), filed on Oct. 28, 2004, entitled, “Expandable Stent Having A Dissolvable Portion.”
BACKGROUND OF INVENTION
• 1. Field of the Invention
• The present invention relates to intravascular stents and methods of treating aneurysms, and more particularly, this invention relates to a covered stent which may be modified to treat an aneurysm located adjacent to a bifurcated blood vessel while permitting blood to flow through the bifurcated vessel, and methods of use thereof.
• 2. Description of the Prior Art
• Expandable stents are widely used in the treatment of vascular diseases. Typically, a stent is inserted into a stenosed blood vessel after an angioplasty to prevent the restenosis of the blood vessels. Expandable stents are also used as aneurysm covers. When a stent is placed across an aneurysm, the blood flow into the aneurysm is decreased. Decreased blood flow within an aneurysm promotes the formation of a thrombus within the aneurysm which ultimately aids in protecting the aneurysm from further expansion or rupture.
• Optimally, a covered stent is positioned across an aneurysm to completely restrict the blood flow into the aneurysm. Such covered stents, typically covered with a material such as PTFE provide suitable aneurysm covers; however, these stents have certain limitations. For example, covered stents impede blood flow into or out of branching blood vessels. Thus, a covered stent may not be suitable for treating an aneurysm at or near a bifurcated blood vessel.
• Several patents and patent applications disclose covered stents with various modifications which tend to avoid these limitations inherent with typical covered stents. For example, U.S. Pat. No. 6,030,414, entitled “Variable Stent And Method For Treatment Of Arterial Disease,” discloses a covered stent having predetermined and sized lateral openings for the treatment of arterial disease at or around the intersection of multiple arteries; U.S. Pat. No. 6,497,722, entitled “Method And Apparatus For In-Vivo Tailored Stents Indicated For Use In Tortuous Anatomy,” discloses a stent having a side opening to allow unimpeded blood flow to a branching vessel at the point of stenting; and, U.S. Patent Application Publication No. 2003/0074049, entitled “Covered Stents And Systems For Deploying Covered Stents,” discloses a covered stent which may be perforated in order to allow blood flow into a side branch or bifurcated vessel.
• Also, U.S. patent application Ser. No. 10/696,667, filed on Oct. 29, 2003 (Attorney Docket No. CRD5038), assigned to the same assignee as the subject patent application discloses a covered stent for treating an aneurysm which includes a skeletal stent structure with removable slat members to permit blood to flow through a bifurcated blood vessel. Upon deployment, one or more of the slats may be removed to allow blood to flow through portions of the stent structure while others of the slats are left in place to seal the neck of an adjacent aneurysm. This patent application made of record in the subject patent application and is hereby incorporated and made a part of the subject application.
SUMMARY OF THE INVENTION
• In accordance with one aspect of the present invention there is provided an aneurysm treatment device including an expandable stent which takes the form of a small diameter skeletal tubular member having a thin wall. The wall of the skeletal tubular member defines a plurality of cells which are formed by a plurality of interconnected strut members. Also, a covering extends over a portion of the expandable stent. The covering exhibits the characteristic of, upon being actuated by applying an activating agent to the covering, dissolving to thereby expose a portion of the expandable stent.
• In accordance with another aspect of the present invention, the expandable stent takes the form of a metallic structural tubular member and the covering is formed from a polymer, such as ethylene vinyl alcohol. The activating agent may take the form of dimethylsulfoxide. If the activating agent is applied to a selective portion of the coating that portion dissolves to expose the underlying porous stent to permit blood to flow through the stent while the balance of the stent remains intact to cover an aneurysm.
• In accordance with another aspect of the present invention, there is provided a method of treating an aneurysm including the method steps of providing an expandable stent including a skeletal tubular member having a covering disposed onto the skeletal tubular member, inserting the expandable stent into the blood vessel of a patient, advancing the expandable stent until the covering on the stent is aligned with and covers an aneurysm in the blood vessel, expanding the expandable stent so that the covering extends across the neck of an aneurysm, and applying an activating agent to a portion of the covering to cause that portion of the covering to dissolve to expose a portion of the underlying stent in order to permit blood to flow through that portion of the stent while maintaining a seal across the aneurysm.
• In accordance with another aspect of the present invention there is provided a method for treating an aneurysm including the steps of providing an expandable stent including a skeletal tubular member having a covering disposed onto the skeletal tubular member, inserting said expandable stent into a blood vessel of a patient, advancing the expandable stent until the covering on the stent is aligned with and covers an aneurysm in the blood vessel and also covers a branching blood vessel, expanding the skeletal tubular member so that the covering extends across the neck of the aneurysm and across a branching vessel, inserting a drug delivery catheter into the branching vessel and advancing the distal tip of the drug delivery catheter to have position proximate to a portion of the covering of the stent which extends across the branching vessel, and applying an activating agent through the drug delivery catheter to that portion of the covering to thereby cause that portion of the covering to dissolve and expose a portion of the porous tubular member thereby permitting blood to flow to or from the branching vessel.
• In accordance with still another aspect of the present invention, there is provided an aneurysm treatment device which includes an expandable tubular member having a thin wall and in which the wall of the tubular member is formed of a material which exhibits the characteristic that when an activating agent is applied to a portion of the wall of the tubular member that portion of the wall dissolves to provide a passageway through the wall. The wall of the expandable tubular member may be formed of ethylene vinyl alcohol and the activating agent may take the form of dimethylsulfoxide.
BRIEF DESCRIPTION OF THE DRAWINGS
• FIG. 1 is an enlarged oblique view of a covered stent device comprised of an expandable skeletal support member and a outer covering which extends over a portion of the support member;
• FIG. 2 is an enlarged elevational view of the covered stent placed adjacent to the neck of an aneurysm and across a main artery at a bifurcation;
• FIG. 3 is an enlarged elevational view of the covered stent illustrating an activating agent being applied to a portion of the covering device at a branching vessel; and,FIG. 4 is an enlarged elevational view of the covered stent with a portion of the covering removed to expose the underlying porous skeletal stent.
DESCRIPTION OF THE PREFERRED EMBODIMENT
• FIG. 1 illustrates an expandable coveredstent10 which may be used to treat an aneurysm, such as an aneurysm within the brain, occurring in a blood vessel at or near a bifurcation in the blood vessel. In the preferred embodiment of the present invention, the coveredstent10 is comprised of an expandableskeletal stent12 and anouter covering14 disposed on the outer surface of theskeletal stent12.
• More particularly, theskeletal stent12 includes a plurality of cells which are formed by a plurality of interconnected strut members to thereby define a structure which may be placed into a vessel and after being properly aligned may then be expanded. Theskeletal stent12 may either take the form of a balloon expandable stent or a self-expanding stent. An example of such a self expanding stent is disclosed in U.S. Pat. No. 6,673,106, entitled, “Intravascular Stent Device,” and an example of a stent and stent deployment system is disclosed in U.S. patent application Ser. No. 10/365,288, entitled, “Expandable Stent And Delivery System,” filed on Feb. 12, 2003, Attorney Docket No. CRD1062. This patent and patent application are assigned to the same assignee as the present patent application and are hereby made of record and incorporated by reference into the present patent application.
• The outer covering14 preferably takes the form of a polymer, such as a thin film of ethylene vinyl alcohol which may be bonded to the surface of theskeletal stent12. This covering, as will be described in more detail, serves to cover the neck of the aneurysm. This material exhibits the characteristic of, upon being activated by applying an agent to the covering, dissolving to expose a portion of the underlying expandable stent.
• FIG. 2 illustrates the coveredstent10 ofFIG. 1 positioned within a blood vessel such that theouter covering14 extends across the neck of ananeurysm16. As with almost all vascular stents, the covered stent is initially compressed and is passed through the vessel and is then expanded with a balloon catheter or is permitted to self expand into the position as shown. Also, since theaneurysm16 occurs at a location adjacent to aparent vessel18 which serves to feed thebranch vessels20,22, with the placement of the stent with theouter covering14 covering the neck of theaneurysm16, it will also obstruct the flow of blood from theparent vessel18 into the branchingvessels20,22. Aneurysms frequently occur at a bifurcated junction vessels, therefore, it should be observed that one of the major advantages of the present invention is that of providing a covered stent which serves to provide a covering for the neck of the aneurysm while at the same time being modified to allow blood to flow from a bifurcated vessel to other vessels. This modification will be explained in more detail with respect to the following drawings.
• FIG. 3, which is similar toFIG. 2, illustrates the coveredstent10 which extends from thebranch vessel20 to thebranch vessel22 and is positioned so that the outer covering14 occludes both theaneurysm16 and theparent vessel18. Once the coveredstent10 is properly placed within the blood vessels, adrug delivery catheter24 may be inserted into the vasculature and passed through theparent vessel18 so that thedistal end24aof the drug delivery catheter is positioned in proximity to the outer covering14 of the coveredstent10 at aregion24awhere the outer covering14 occluded theparent vessel18. With theouter covering14 formed of a thin film of ethylene vinyl alcohol, preferably an activatingagent26 such as, for example, dimethylsulfoxide, is applied to theouter covering14 in the region where the outer covering14 occludes theparent vessel18.
• FIG. 4 illustrates the coveredstent10 after application of the activating agent and, as is apparent, the activating agent, or dimethylsulfoxide, has dissolved the covering formed of ethylene vinyl alcohol in the desired region of theparent vessel18 to thereby expose the underlying porousskeletal stent12 atlocation28. Thedrug delivery catheter24 is then removed from the vasculature, with the result that the coveredstent10 serves to occlude the neck of theaneurysm16 while permitting blood to flow through theparent vessel18 and into thebranch vessels20,22.
• In summary, the device of the present invention may be used to treat an aneurysm by providing an expandable stent including a skeletal tubular member having a covering disposed onto the skeletal member, inserting the expandable stent into a blood vessel of a patient, advancing the expandable stent until the covered stent is aligned with and covers an aneurysm in the blood vessel, expanding the skeletal tubular member so that the covering extends across the neck of the aneurysm, and applying an activating agent to a portion of the covering to cause that portion of the covering to dissolve and expose a portion of the underlying skeletal tubular member. Once this method has been performed, the remaining portion of the covering serves as a seal for the aneurysm while permitting blood to flow through all of the adjacent vessels.
• A novel medical device and method to treat an aneurysm at a bifurcation has been disclosed. Although a preferred embodiment of the present invention has been described, it should be understood that various modifications such as for example removal of a portion of the covering by an electrical or electrolytic process, by a heating process or by other processes may be made by one skilled in the art without departing from the scope of the claims which follow.

Claims (8)

1. An aneurysm treatment device comprising:

an expandable stent which takes the form of a small diameter skeletal tubular member having a thin wall, said wall of said skeletal tubular member including a plurality of cells which are formed by a plurality of interconnected strut members; and,

a covering extending over a portion of the expandable stent, said covering exhibiting the characteristic of, upon being activated by applying an agent to said covering, dissolving to expose a portion of the expandable stent.

2. An aneurysm treatment device as defined inclaim 1, wherein the covering is formed of a material which is dissolvable when it comes into contact with an activating agent.

3. An aneurysm treatment device as defined inclaim 2, wherein said expandable stent takes the form of a metallic skeletal tubular member and said covering is formed from a polymer.

4. An aneurysm treatment device as defined inclaim 3, wherein said covering takes the form of ethylene vinyl alcohol and the activating agent takes the form of dimethylsulfoxide.

5. An aneurysm treatment device as defined inclaim 4, wherein the covering takes the form of a thin film of ethylene vinyl alcohol disposed on an outer surface of said expandable stent.

6. An aneurysm treatment device comprising:

an expandable tubular member having a thin wall, said wall of said tubular member is formed of a material exhibiting the characteristic that when an activating agent is applied to a portion of the wall of said tubular member said portion of the wall dissolves to provide a passageway through the wall.

7. An aneurysm treatment device as defined inclaim 6, wherein the wall of said expandable tubular member takes the form of ethylene vinyl alcohol and the activating agent takes the form of dimethylsulfoxide.

8. An aneurysm treatment device as defined inclaim 7, wherein said expandable tubular member takes the form of a thin film of ethylene vinyl alcohol.

Images